It has also been reported that AIM2 deficiency in a AOM/DSS mouse model of colorectal cancer resulted in an increase in tumor load in an inflammasome-independent manner (Akt activation) and was mediated by a non–bone marrow source of AIM2 [127]. The gene discussed is AKT1; the disease is neoplasm.